Position in CAI
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$636,728
+$376,578 QoQ
Shares Held
23,600
+174.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.98%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025Sandia Investment Management LP holds $1,593,938 across 7 Biotechnology names. CAI ranks #1 (39.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
This page
|
23,600 | $636,728 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
5,000 | $398,250 | |
| 3 | IMNM |
Immunome Inc.
|
10,000 | $214,800 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
6,000 | $182,040 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
2,500 | $126,600 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,000 | $35,520 | |
| 7 | ABPO |
Abpro Holdings, Inc.
|
358,427 | $0 |
All Filings in CAI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $636,728 | 23,600 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $260,150 | 8,600 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $267,200 | 10,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||